These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Memantine potentiates cytarabine-induced cell death of acute leukemia correlating with inhibition of K Lowinus T; Heidel FH; Bose T; Nimmagadda SC; Schnöder T; Cammann C; Schmitz I; Seifert U; Fischer T; Schraven B; Bommhardt U Cell Commun Signal; 2019 Jan; 17(1):5. PubMed ID: 30651113 [TBL] [Abstract][Full Text] [Related]
23. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells. Lu C; Hassan HT Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192 [TBL] [Abstract][Full Text] [Related]
24. Oridonin Synergistically Enhances the Pro-Apoptotic Effect of Venetoclax on Acute Myeloid Leukemia Cells by Inhibiting AKT Signaling. Chen L; Li D; Guo X; Cheng C; Wei X Front Biosci (Landmark Ed); 2023 Sep; 28(9):195. PubMed ID: 37796705 [TBL] [Abstract][Full Text] [Related]
25. Concurrent targeting Akt and sphingosine kinase 1 by A-674563 in acute myeloid leukemia cells. Xu L; Zhang Y; Gao M; Wang G; Fu Y Biochem Biophys Res Commun; 2016 Apr; 472(4):662-8. PubMed ID: 26920060 [TBL] [Abstract][Full Text] [Related]
26. Sorafenib induces endometrial carcinoma apoptosis by inhibiting Elk-1-dependent Mcl-1 transcription and inducing Akt/GSK3β-dependent protein degradation. Sun NK; Huang SL; Chang TC; Chao CC J Cell Biochem; 2013 Aug; 114(8):1819-31. PubMed ID: 23463670 [TBL] [Abstract][Full Text] [Related]
27. Binding of Released Bim to Mcl-1 is a Mechanism of Intrinsic Resistance to ABT-199 which can be Overcome by Combination with Daunorubicin or Cytarabine in AML Cells. Niu X; Zhao J; Ma J; Xie C; Edwards H; Wang G; Caldwell JT; Xiang S; Zhang X; Chu R; Wang ZJ; Lin H; Taub JW; Ge Y Clin Cancer Res; 2016 Sep; 22(17):4440-51. PubMed ID: 27103402 [TBL] [Abstract][Full Text] [Related]
28. Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor perifosine in acute myelogenous leukemia cells. Papa V; Tazzari PL; Chiarini F; Cappellini A; Ricci F; Billi AM; Evangelisti C; Ottaviani E; Martinelli G; Testoni N; McCubrey JA; Martelli AM Leukemia; 2008 Jan; 22(1):147-60. PubMed ID: 17928881 [TBL] [Abstract][Full Text] [Related]
29. Meisoindigo is a promising agent with in vitro and in vivo activity against human acute myeloid leukemia. Lee CC; Lin CP; Lee YL; Wang GC; Cheng YC; Liu HE Leuk Lymphoma; 2010 May; 51(5):897-905. PubMed ID: 20233051 [TBL] [Abstract][Full Text] [Related]
30. Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death. Heo SK; Noh EK; Yu HM; Kim DK; Seo HJ; Lee YJ; Cheon J; Koh SJ; Min YJ; Choi Y; Jo JC BMC Cancer; 2020 Dec; 20(1):1193. PubMed ID: 33276759 [TBL] [Abstract][Full Text] [Related]
31. The protein kinase C agonist prostratin induces differentiation of human myeloid leukemia cells and enhances cellular differentiation by chemotherapeutic agents. Shen X; Xiong GL; Jing Y; Xiao H; Cui Y; Zhang YF; Shan YJ; Xing S; Yang M; Liu XL; Dong B; Wang LS; Luo QL; Yu ZY; Cong YW Cancer Lett; 2015 Jan; 356(2 Pt B):686-96. PubMed ID: 25449427 [TBL] [Abstract][Full Text] [Related]
32. Enhanced apoptotic effects by downregulating Mcl-1: evidence for the improvement of photodynamic therapy with Celecoxib. Song J; Chen Q; Xing D Exp Cell Res; 2013 Jun; 319(10):1491-504. PubMed ID: 23524145 [TBL] [Abstract][Full Text] [Related]
33. Targeting the wee1 kinase for treatment of pediatric Down syndrome acute myeloid leukemia. Caldwell JT; Edwards H; Buck SA; Ge Y; Taub JW Pediatr Blood Cancer; 2014 Oct; 61(10):1767-73. PubMed ID: 24962331 [TBL] [Abstract][Full Text] [Related]
34. Gö6976, a FLT3 kinase inhibitor, exerts potent cytotoxic activity against acute leukemia via inhibition of survivin and MCL-1. Yoshida A; Ookura M; Zokumasu K; Ueda T Biochem Pharmacol; 2014 Jul; 90(1):16-24. PubMed ID: 24735609 [TBL] [Abstract][Full Text] [Related]
35. Superior activity of the combination of histone deacetylase inhibitor LAQ824 and the FLT-3 kinase inhibitor PKC412 against human acute myelogenous leukemia cells with mutant FLT-3. Bali P; George P; Cohen P; Tao J; Guo F; Sigua C; Vishvanath A; Scuto A; Annavarapu S; Fiskus W; Moscinski L; Atadja P; Bhalla K Clin Cancer Res; 2004 Aug; 10(15):4991-7. PubMed ID: 15297399 [TBL] [Abstract][Full Text] [Related]
36. Chidamide in FLT3-ITD positive acute myeloid leukemia and the synergistic effect in combination with cytarabine. Li X; Yan X; Guo W; Huang X; Huang J; Yu M; Ma Z; Xu Y; Huang S; Li C; Zhou Y; Jin J Biomed Pharmacother; 2017 Jun; 90():699-704. PubMed ID: 28419965 [TBL] [Abstract][Full Text] [Related]
37. Cytarabine-induced destabilization of MCL1 mRNA and protein triggers apoptosis in leukemia cells. Chiou JT; Hsu CC; Hong YC; Lee YC; Chang LS Biochem Pharmacol; 2023 May; 211():115494. PubMed ID: 36924905 [TBL] [Abstract][Full Text] [Related]
38. Amsacrine-induced apoptosis of human leukemia U937 cells is mediated by the inhibition of AKT- and ERK-induced stabilization of MCL1. Lee YC; Chen YJ; Huang CH; Chang LS Apoptosis; 2017 Mar; 22(3):406-420. PubMed ID: 27757735 [TBL] [Abstract][Full Text] [Related]
39. High fluence low-power laser irradiation induces apoptosis via inactivation of Akt/GSK3β signaling pathway. Huang L; Wu S; Xing D J Cell Physiol; 2011 Mar; 226(3):588-601. PubMed ID: 20683916 [TBL] [Abstract][Full Text] [Related]
40. Homoharringtonine enhances cytarabine-induced apoptosis in acute myeloid leukaemia by regulating the p38 MAPK/H2AX/Mcl-1 axis. Qiu Y; Bai L; Zhao H; Mei X BMC Cancer; 2024 Apr; 24(1):520. PubMed ID: 38658865 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]